Jane Street’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $38.7M | Sell |
71,400
-74,900
| -51% | -$42.2M | ﹤0.01% | 1608 |
|
|
2026
Q1 | $86.8M | Buy |
146,300
+44,200
| +43% | +$22M | 0.01% | 714 |
|
|
2025
Q4 | $49.7M | Hold |
102,100
| – | – | 0.01% | 946 |
|
|
2025
Q3 | $42.8M | Buy |
102,100
+85,600
| +519% | +$28.8M | 0.01% | 1043 |
|
|
2025
Q2 | $4.74M | Buy |
16,500
+13,800
| +511% | +$4.12M | ﹤0.01% | 3073 |
|
|
2025
Q1 | $832K | Buy |
2,700
+1,400
| +108% | +$480K | ﹤0.01% | 5914 |
|
|
2024
Q4 | $459K | Sell |
1,300
-39,500
| -97% | -$14.5M | ﹤0.01% | 6957 |
|
|
2024
Q3 | $14.6M | Sell |
40,800
-437,300
| -91% | -$148M | ﹤0.01% | 1536 |
|
|
2024
Q2 | $152M | Sell |
478,100
-132,400
| -22% | -$35M | 0.03% | 272 |
|
|
2024
Q1 | $140M | Buy |
610,500
+605,700
| +12,619% | +$137M | 0.03% | 293 |
|
|
2023
Q4 | $1.06M | Sell |
4,800
-9,700
| -67% | -$2.24M | ﹤0.01% | 5473 |
|
|
2023
Q3 | $3.28M | Buy |
14,500
+10,400
| +254% | +$2.4M | ﹤0.01% | 3230 |
|
|
2023
Q2 | $905K | Sell |
4,100
-53,100
| -93% | -$11.8M | ﹤0.01% | 5354 |
|
|
2023
Q1 | $12.8M | Sell |
57,200
-1,600
| -3% | -$394K | 0.01% | 1385 |
|
|
2022
Q4 | $16.4M | Buy |
58,800
+22,400
| +62% | +$5.65M | 0.01% | 1157 |
|
|
2022
Q3 | $7.62M | Sell |
36,400
-32,100
| -47% | -$7.18M | ﹤0.01% | 2012 |
|
|
2022
Q2 | $16.1M | Buy |
68,500
+4,800
| +8% | +$976K | 0.01% | 1292 |
|
|
2022
Q1 | $11.4M | Buy |
63,700
+38,500
| +153% | +$7.33M | ﹤0.01% | 1827 |
|
|
2021
Q4 | $5.45M | Buy |
25,200
+4,700
| +23% | +$923K | ﹤0.01% | 2726 |
|
|
2021
Q3 | $3.78M | Sell |
20,500
-26,400
| -56% | -$5.2M | ﹤0.01% | 3214 |
|
|
2021
Q2 | $8.41M | Buy |
46,900
+29,500
| +170% | +$5.62M | ﹤0.01% | 1916 |
|
|
2021
Q1 | $2.91M | Buy |
17,400
+1,600
| +10% | +$267K | ﹤0.01% | 3313 |
|
|
2020
Q4 | $2.4M | Sell |
15,800
-3,000
| -16% | -$394K | ﹤0.01% | 3186 |
|
|
2020
Q3 | $1.9M | Buy |
18,800
+900
| +5% | +$98.8K | ﹤0.01% | 3122 |
|
|
2020
Q2 | $2.17M | Buy |
+17,900
| New | +$2.01M | ﹤0.01% | 2950 |
|
|
2017
Q4 | – | Sell |
-1,900
| Closed | -$223K | – | 5214 |
|
|
2017
Q3 | $223K | Buy |
+1,900
| New | +$243K | ﹤0.01% | 4018 |
|
|
2016
Q4 | – | Sell |
-1,900
| Closed | -$224K | – | 4649 |
|
|
2016
Q3 | $224K | Buy |
+1,900
| New | +$228K | ﹤0.01% | 3596 |
|
Other funds holding UTHR
ACA
JT
Jane Street's UTHR Position: Q2 2026 in Review
Jane Street increased its United Therapeutics (UTHR) stake by 10,263% in Q2 2026, buying an estimated $159M and bringing the position to 285,926 shares worth $155M. The position accounts for 0.01% of the portfolio, ranked #701.
Jane Street first reported a position in UTHR in Q3 2013 and has held it in 43 quarters since. 881 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.
- Jane Street held 285,926 shares of United Therapeutics worth $155M as of Q2 2026.
- Jane Street bought 283,167 United Therapeutics shares in Q2 2026, an estimated $159M.
- United Therapeutics made up 0.01% of Jane Street's portfolio in Q2 2026, its #701 holding.
- Jane Street first reported a position in United Therapeutics in Q3 2013 and has held it in 43 quarters since.
- 881 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.
Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.